X-18642022-GC-CT

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_000330.4(RS1):​c.656_657delGCinsAG​(p.Cys219*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 23)

Consequence

RS1
NM_000330.4 stop_gained

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 7.57
Variant links:
Genes affected
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-18642022-GC-CT is Pathogenic according to our data. Variant chrX-18642022-GC-CT is described in ClinVar as [Pathogenic]. Clinvar id is 2123578.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RS1NM_000330.4 linkc.656_657delGCinsAG p.Cys219* stop_gained ENST00000379984.4 NP_000321.1 O15537
RS1XM_047442337.1 linkc.560_561delGCinsAG p.Cys187* stop_gained XP_047298293.1
CDKL5NM_001037343.2 linkc.2714-3985_2714-3984delGCinsCT intron_variant Intron 19 of 21 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.2714-3985_2714-3984delGCinsCT intron_variant Intron 18 of 20 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RS1ENST00000379984.4 linkc.656_657delGCinsAG p.Cys219* stop_gained 1 NM_000330.4 ENSP00000369320.3 O15537
CDKL5ENST00000379989.6 linkc.2714-3985_2714-3984delGCinsCT intron_variant Intron 19 of 21 1 ENSP00000369325.3 O76039-1
CDKL5ENST00000379996.7 linkc.2714-3985_2714-3984delGCinsCT intron_variant Intron 18 of 20 1 ENSP00000369332.3 O76039-1
RS1ENST00000476595.1 linkn.1147_1148delGCinsAG non_coding_transcript_exon_variant Exon 5 of 5 1

Frequencies

GnomAD3 genomes
Cov.:
23
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Apr 09, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the RS1 protein in which other variant(s) (p.Cys223Tyr) have been determined to be pathogenic (PMID: 20061330, 22245991; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with RS1-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change creates a premature translational stop signal (p.Cys219*) in the RS1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 6 amino acid(s) of the RS1 protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-18660142; API